Intravenous Dexamethasone and Dexmedetomidine on the Analgesic Efficacy of Erector Spinae Plane Block for Posterior Lumbar Interbody Fusion Surgery
Overview
- Phase
- Not Applicable
- Intervention
- Dexamethasone and dexmedetomidine
- Conditions
- Dexamethasone
- Sponsor
- Huazhong University of Science and Technology
- Enrollment
- 120
- Locations
- 1
- Primary Endpoint
- The time to first rescue analgesic request
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
Patients having lumbar spinal fusion often complain about severe postoperative pain and postoperative rehabilitation process can be affected negatively. Postoperative pain that cannot be well controlled may lead to delayed mobilization, pulmonary and thromboembolic complications, prolonged hospital stays, and chronic pain syndromes. Pain after spinal surgery can arise from several different tissues, such as the vertebrae, disks, ligaments, dura, facet joint, muscle, fascia, and subcutaneous and cutaneous tissues.
Ultrasound-guided lumbar erector spinae plane block (ESPB) has been shown to reduce postoperative pain in patients undergoing posterior lumbar interbody fusion (PLIF). However, the duration of analgesia after single-shot ESPB with commonly used local anesthetics is reported to be no more than 12 h, which often not long enough to provide satisfactory postoperative pain relief, as the pain typically lasts for several days. Compared with perineural route, intravenous additives to local anesthetics are commonly accepted as its safety and efficiency have been reported. Moreover, co-administration of intravenous dexamethasone and dexmedetomidine significantly prolonged the time to first rescue analgesic request after single-shot interscalene brachial plexus block. However, more data are needed especially for lumbar ESPB.
Investigators
Xi Wu
Principal Investigator, Department of Anesthesiology, Union Hospital of Tongji Medical College
Huazhong University of Science and Technology
Eligibility Criteria
Inclusion Criteria
- •Age 18-65 yrs
- •American Society of Anesthesiologists physical statusⅠ-Ⅲ
- •Involvement of ≤3 spinal levels
- •Undergo elective posterior lumbar interbody fusion
- •Informed consent
Exclusion Criteria
- •A known allergy to the drugs being used
- •Pre-existing neuropsychiatric disorders or language barrier
- •Analgesics intake, history of substance abuse
- •Contraindications to peripheral nerve block
- •Acute cerebrovascular disease
- •Severe liver failure
- •Uncontrolled low blood pressure
- •Sinus bradycardia or atrioventricular block
Arms & Interventions
DD group
co-administered intravenous dexamethasone 10 mg and dexmedetomidine 1 ug/kg
Intervention: Dexamethasone and dexmedetomidine
DD group
co-administered intravenous dexamethasone 10 mg and dexmedetomidine 1 ug/kg
Intervention: Ultrasound-guided lumbar erector spinae plane block
DD group
co-administered intravenous dexamethasone 10 mg and dexmedetomidine 1 ug/kg
Intervention: PCIA
D group
intravenous dexmedetomidine 1 ug/kg
Intervention: Dexmedetomidine
D group
intravenous dexmedetomidine 1 ug/kg
Intervention: Ultrasound-guided lumbar erector spinae plane block
D group
intravenous dexmedetomidine 1 ug/kg
Intervention: PCIA
Outcomes
Primary Outcomes
The time to first rescue analgesic request
Time Frame: Up to 48 postoperative hrs
The cumulative opioid consumption
Time Frame: At 24 postoperative hours
Secondary Outcomes
- Postoperative hospital length of stay(Up to 3 weeks)
- Adverse events(Up to 48 postoperative hrs)
- The pain scores determined by the numeric rating scale (NRS, 0-10)(At 6, 12, 18, 24, 30, 36, 42, and 48 hrs after the surgery)
- Incidence of postoperative nausea and vomiting(Up to 24 postoperative hrs)